{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:27:20Z","timestamp":1795091240817,"version":"4.10.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41391-026-01081-z","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:11:18Z","timestamp":1769872278000},"page":"625-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Radical prostatectomy without prior biopsy: an initial decision-making algorithm based on PSMA PET\/mpMRI"],"prefix":"10.1038","volume":"29","author":[{"given":"Zhuoran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1520-9455","authenticated-orcid":false,"given":"Jin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanxin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundong","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baichuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Ci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9705-0281","authenticated-orcid":false,"given":"Shaoxi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-0792","authenticated-orcid":false,"given":"Songliang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4036-9470","authenticated-orcid":false,"given":"Baojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"1081_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","volume":"71","author":"M Borghesi","year":"2017","unstructured":"Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, et al. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol. 2017;71:353\u201365.","journal-title":"Eur Urol"},{"key":"1081_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.euo.2019.08.007","volume":"2","author":"O Wegelin","year":"2019","unstructured":"Wegelin O, Exterkate L, van der Leest M, Kelder JC, Bosch J, Barentsz JO, et al. Complications and adverse events of three magnetic resonance imaging-based target biopsy techniques in the diagnosis of prostate cancer among men with prior negative biopsies: results from the Future Trial, a multicentre randomised controlled trial. Eur Urol Oncol. 2019;2:617\u201324.","journal-title":"Eur Urol Oncol"},{"key":"1081_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.eururo.2012.01.050","volume":"61","author":"JI Epstein","year":"2012","unstructured":"Epstein JI, Feng Z, Trock BJ, Pierorazio PM. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol. 2012;61:1019\u201324.","journal-title":"Eur Urol"},{"key":"1081_CR4","doi-asserted-by":"crossref","unstructured":"Huang C, He S, He Q, Gong Y, Song G, Zhou L. Determination of whether apex or non-apex prostate cancer is the best candidate for the use of prostate-specific antigen density to predict pathological grade group upgrading and upstaging after radical prostatectomy. J Clin Med. 2023;12:1659.","DOI":"10.3390\/jcm12041659"},{"key":"1081_CR5","unstructured":"Cornford P, Tilki D, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines presented at the EAU Annual Congress Madrid 2025 edn. Arnhem, the Netherlands: EAU Guidelines Office; 2025."},{"key":"1081_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.eururo.2021.11.019","volume":"82","author":"VH Meissner","year":"2022","unstructured":"Meissner VH, Rauscher I, Schwamborn K, Neumann J, Miller G, Weber W, et al. Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. Eur Urol. 2022;82:156\u201360.","journal-title":"Eur Urol"},{"key":"1081_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/pros.24446","volume":"83","author":"S Niu","year":"2023","unstructured":"Niu S, Liu Y, Ding X, Xu Y, Yu H, Feng X, et al. 18) F-DCFPyL positron emission tomography\/magnetic resonance imaging-guided ultrasound fusion biopsy is an identical pathway in prostate cancer diagnosis. Prostate. 2023;83:142\u201350.","journal-title":"Prostate"},{"key":"1081_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/bju.14794","volume":"124","author":"MJ Scheltema","year":"2019","unstructured":"Scheltema MJ, Chang JI, Stricker PD, van Leeuwen PJ, Nguyen QA, Ho B, et al. Diagnostic accuracy of (68) Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of (68) Ga-PSMA PET to mpMRI. BJU Int. 2019;124:42\u20139.","journal-title":"BJU Int"},{"key":"1081_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/JU.0000000000002293","volume":"207","author":"S Raveenthiran","year":"2022","unstructured":"Raveenthiran S, Yaxley WJ, Franklin T, Coughlin G, Roberts M, Gianduzzo T, et al. Findings in 1,123 Men with Preoperative (68)Ga-prostate-specific membrane antigen positron emission tomography\/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: implications for the diagnosis and management of prostate cancer. J Urol. 2022;207:573\u201380.","journal-title":"J Urol"},{"key":"1081_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"L Emmett","year":"2021","unstructured":"Emmett L, Buteau J, Papa N, Moon D, Thompson J, Roberts MJ, et al. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective Multicentre study. Eur Urol. 2021;80:682\u20139.","journal-title":"Eur Urol"},{"key":"1081_CR11","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","volume":"70","author":"M Eiber","year":"2016","unstructured":"Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I, et al. Simultaneous (68)Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer. Eur Urol. 2016;70:829\u201336.","journal-title":"Eur Urol"},{"key":"1081_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ajur.2024.07.006","volume":"12","author":"S Niu","year":"2025","unstructured":"Niu S, Liu Y, Ao L, Ding X, Chang X, Li J, et al. Comparison between (18)F-DCFPyL PET\/MRI-guided ultrasound fusion targeted biopsy and systematic biopsy for tumor detection and grading in selected patients: a prospective randomized controlled trial. Asian J Urol. 2025;12:43\u201350.","journal-title":"Asian J Urol"},{"key":"1081_CR13","doi-asserted-by":"crossref","unstructured":"Liu R, Yin L, Ma S, Yang F, Lian Z, Wang M, et al. Preliminary clinical practice of radical prostatectomy without preoperative biopsy. Chin Med J. 2025;138:721\u201328.","DOI":"10.1097\/CM9.0000000000003204"},{"key":"1081_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/JU.0000000000004025","volume":"212","author":"S Niu","year":"2024","unstructured":"Niu S, Ding X, Liu B, Ao L, Wang H, Chen W, et al. Radical prostatectomy without prior biopsy in selected patients evaluated by (18)F-labeled prostate-specific membrane antigen-ligand positron emission tomography\/computed tomography and multiparameter magnetic resonance imaging: a single-center, prospective, single-arm trial. J Urol. 2024;212:280\u20139.","journal-title":"J Urol"},{"key":"1081_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2967\/jnumed.117.198119","volume":"59","author":"M Eiber","year":"2018","unstructured":"Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M, et al. Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-Ligand PET\/CT. J Nucl Med. 2018;59:469\u201378.","journal-title":"J Nucl Med"},{"key":"1081_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eururo.2012.05.045","volume":"62","author":"V Ficarra","year":"2012","unstructured":"Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012;62:405\u201317.","journal-title":"Eur Urol"},{"key":"1081_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2019.01.048","volume":"76","author":"F Preisser","year":"2019","unstructured":"Preisser F, Chun FKH, Pompe RS, Heinze A, Salomon G, Graefen M, et al. Persistent prostate-specific antigen after radical prostatectomy and its impact on oncologic outcomes. Eur Urol. 2019;76:106\u201314.","journal-title":"Eur Urol"},{"key":"1081_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.eururo.2018.12.014","volume":"75","author":"M Assel","year":"2019","unstructured":"Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A, et al. Guidelines for reporting of statistics for clinical research in urology. Eur Urol. 2019;75:358\u201367.","journal-title":"Eur Urol"},{"key":"1081_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86:148\u201363.","journal-title":"Eur Urol"},{"key":"1081_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11701-018-0848-8","volume":"13","author":"P Banapour","year":"2019","unstructured":"Banapour P, Elliott P, Jabaji R, Parekh A, Pathak A, Merchant M, et al. Safety and feasibility of outpatient robot-assisted radical prostatectomy. J Robot Surg. 2019;13:261\u20135.","journal-title":"J Robot Surg"},{"key":"1081_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1089\/end.2021.0643","volume":"36","author":"J Li","year":"2022","unstructured":"Li J, Li Y, Cao D, Xia Z, Meng C, Peng L, et al. Outpatient vs inpatient robot-assisted radical prostatectomy: an evidence-based analysis of comparative outcomes. J Endourol. 2022;36:468\u201376.","journal-title":"J Endourol"},{"key":"1081_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","volume":"70","author":"M de Rooij","year":"2016","unstructured":"de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM. Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol. 2016;70:233\u201345.","journal-title":"Eur Urol"},{"key":"1081_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/bju.16547","volume":"135","author":"T Li","year":"2025","unstructured":"Li T, Graham PL, Cao B, Nalavenkata S, Patel MI, Kim L. Accuracy of MRI in detecting seminal vesicle invasion in prostate cancer: a systematic review and meta-analysis. BJU Int. 2025;135:17\u201328.","journal-title":"BJU Int"},{"key":"1081_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/JU.0000000000001698","volume":"206","author":"KJ Pienta","year":"2021","unstructured":"Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, et al. A phase 2\/3 prospective multicenter study of the diagnostic accuracy of prostate-specific membrane antigen PET\/CT with (18)F-DCFPyL in prostate cancer patients (OSPREY). J Urol. 2021;206:52\u201361.","journal-title":"J Urol"},{"key":"1081_CR25","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","volume":"7","author":"TA Hope","year":"2021","unstructured":"Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, et al. Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial. JAMA Oncol. 2021;7:1635\u201342.","journal-title":"JAMA Oncol"},{"key":"1081_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/JU.0000000000000531","volume":"203","author":"LWM van Kalmthout","year":"2020","unstructured":"van Kalmthout LWM, van Melick HHE, Lavalaye J, Meijer RP, Kooistra A, de Klerk JMH, et al. Prospective validation of gallium-68 prostate-specific membrane antigen positron emission tomography\/computerized tomography for primary staging of prostate cancer. J Urol. 2020;203:537\u201345.","journal-title":"J Urol"},{"key":"1081_CR27","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395:1208\u201316.","journal-title":"Lancet"},{"key":"1081_CR28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.eururo.2009.12.034","volume":"57","author":"J Engel","year":"2010","unstructured":"Engel J, Bastian PJ, Baur H, Beer V, Chaussy C, Gschwend JE, et al. Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol. 2010;57:754\u201361.","journal-title":"Eur Urol"},{"key":"1081_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100597","volume":"7","author":"M von Deimling","year":"2022","unstructured":"von Deimling M, Rajwa P, Tilki D, Heidenreich A, Pallauf M, Bianchi A, et al. The current role of precision surgery in oligometastatic prostate cancer. ESMO Open. 2022;7:100597.","journal-title":"ESMO Open"},{"key":"1081_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.urolonc.2017.01.001","volume":"35","author":"MJ Metcalfe","year":"2017","unstructured":"Metcalfe MJ, Smaldone MC, Lin DW, Aparicio AM, Chapin BF. Role of radical prostatectomy in metastatic prostate cancer: a review. Urol Oncol. 2017;35:125\u201334.","journal-title":"Urol Oncol"},{"key":"1081_CR31","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/ijc.29894","volume":"138","author":"CK Zhou","year":"2016","unstructured":"Zhou CK, Check DP, Lortet-Tieulent J, Laversanne M, Jemal A, Ferlay J, et al. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int J Cancer. 2016;138:1388\u2013400.","journal-title":"Int J Cancer"},{"key":"1081_CR32","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/jmri.26743","volume":"50","author":"E Zanelli","year":"2019","unstructured":"Zanelli E, Giannarini G, Cereser L, Zuiani C, Como G, Pizzolitto S, et al. Head-to-head comparison between multiparametric MRI, the Partin tables, Memorial Sloan Kettering Cancer Center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy. J Magn Reson Imaging. 2019;50:1604\u201313.","journal-title":"J Magn Reson Imaging"},{"key":"1081_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euo.2021.08.001","volume":"5","author":"A Stabile","year":"2022","unstructured":"Stabile A, Pellegrino A, Mazzone E, Cannoletta D, de Angelis M, Barletta F, et al. Can negative prostate-specific membrane antigen positron emission tomography\/computed tomography avoid the need for pelvic lymph node dissection in newly diagnosed prostate cancer patients? A systematic review and meta-analysis with backup histology as reference standard. Eur Urol Oncol. 2022;5:1\u201317.","journal-title":"Eur Urol Oncol"},{"key":"1081_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.eururo.2012.05.047","volume":"62","author":"G Novara","year":"2012","unstructured":"Novara G, Ficarra V, Mocellin S, Ahlering TE, Carroll PR, Graefen M, et al. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol. 2012;62:382\u2013404.","journal-title":"Eur Urol"},{"key":"1081_CR35","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.eururo.2013.05.026","volume":"65","author":"B Yuh","year":"2014","unstructured":"Yuh B, Artibani W, Heidenreich A, Kimm S, Menon M, Novara G, et al. The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review. Eur Urol. 2014;65:918\u201327.","journal-title":"Eur Urol"},{"key":"1081_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.eururo.2015.06.020","volume":"68","author":"F Abdollah","year":"2015","unstructured":"Abdollah F, Sood A, Sammon JD, Hsu L, Beyer B, Moschini M, et al. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients. Eur Urol. 2015;68:497\u2013505.","journal-title":"Eur Urol"},{"key":"1081_CR37","doi-asserted-by":"crossref","unstructured":"Milonas D, Venclovas Z, Sasnauskas G, Ruzgas T. The Significance of Prostate Specific Antigen Persistence In Prostate Cancer Risk Groups On Long-term Oncological Outcomes. Cancers. 2021;13:2453.","DOI":"10.3390\/cancers13102453"},{"key":"1081_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.euros.2025.03.006","volume":"75","author":"TFW Soeterik","year":"2025","unstructured":"Soeterik TFW, Wu X, Van den Bergh RCN, Kesch C, Zattoni F, Falagario U, et al. Personalised prostate cancer diagnosis: evaluating biomarker-based approaches to reduce unnecessary magnetic resonance imaging and biopsy procedures. Eur Urol Open Sci. 2025;75:106\u201319.","journal-title":"Eur Urol Open Sci"},{"key":"1081_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.euo.2022.09.005","volume":"6","author":"M Baboudjian","year":"2023","unstructured":"Baboudjian M, Gondran-Tellier B, Touzani A, Martini A, Diamand R, Roche JB, et al. Magnetic resonance imaging-based T-staging to predict biochemical recurrence after radical prostatectomy: a step towards the iTNM classification. Eur Urol Oncol. 2023;6:406\u201313.","journal-title":"Eur Urol Oncol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01081-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T21:44:46Z","timestamp":1786657486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01081-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1038\/s41391-026-01081-z","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent for publication of identifying information\/images in this manuscript was obtained from the individual(s).","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}